Technology ❯ Biotechnology

mRNA Technology

Vaccine Development Vaccine Technology Drug Development Vaccine Production Vaccine Innovation Cancer Research Innovations Research and Development Pharmaceutical Technology Vaccine Delivery Therapeutics Cancer Therapy Clinical Trials mRNA-1083 Cancer Vaccines Artificial Intelligence Drug Delivery Systems

Moderna Scraps CMV Vaccine Program After Phase 3 Failure

The company says the setback does not change its financial outlook.

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

US Cuts $500 Million in mRNA Vaccine Research Funding

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy